{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:51:33Z","timestamp":1790423493504,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:00:00Z","timestamp":1436400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/hr.2015.77","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T06:01:49Z","timestamp":1436421709000},"page":"741-750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome"],"prefix":"10.1038","volume":"38","author":[{"given":"Yuuri","family":"Takeshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohzo","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,9]]},"reference":[{"key":"BFhr201577_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1387-2656(06)12008-6","volume":"12","author":"TJ Cole","year":"2006","unstructured":"Cole TJ . Glucocorticoid action and the development of selective glucocorticoid receptor ligands. Biotechnol Annu Rev 2006; 12: 269\u2013300.","journal-title":"Biotechnol Annu Rev"},{"key":"BFhr201577_CR2","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/S0735-1097(03)00493-5","volume":"41","author":"ML Muiesan","year":"2003","unstructured":"Muiesan ML, Lupia M, Salvetti M, Grigoletto C, Sonino N, Boscaro M, Rosei EA, Mantero F, Fallo F . Left ventricular structural and functional characteristics in Cushing's syndrome. J Am Coll Cardiol 2003; 41: 2275\u20132279.","journal-title":"J Am Coll Cardiol"},{"key":"BFhr201577_CR3","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1006\/jmcc.1999.0990","volume":"31","author":"RM Whitehurst Jr","year":"1999","unstructured":"Whitehurst RM Jr, Zhang M, Bhattacharjee A, Li M . Dexamethasone-induced hypertrophy in rat neonatal cardiac myocytes involves an elevated L-type Ca2+ current. J Mol Cell Cardiol 1999; 31: 1551\u20131558.","journal-title":"J Mol Cell Cardiol"},{"key":"BFhr201577_CR4","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.106.653964","volume":"115","author":"G Guder","year":"2007","unstructured":"Guder G, Bauersachs J, Frantz S, Weismann D, Allolio B, Ertl G, Angermann CE, Stork S . Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation 2007; 115: 1754\u20131761.","journal-title":"Circulation"},{"key":"BFhr201577_CR5","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1210\/en.2012-1563","volume":"153","author":"R Ren","year":"2012","unstructured":"Ren R, Oakley RH, Cruz-Topete D, Cidlowski JA . Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis. Endocrinology 2012; 153: 5346\u20135360.","journal-title":"Endocrinology"},{"key":"BFhr201577_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.mce.2013.03.007","volume":"380","author":"AJ Rose","year":"2013","unstructured":"Rose AJ, Herzig S . Metabolic control through glucocorticoid hormones: an update. Mol Cell Endocrinol 2013; 380: 65\u201378.","journal-title":"Mol Cell Endocrinol"},{"key":"BFhr201577_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jsbmb.2010.02.010","volume":"122","author":"AJ Rose","year":"2010","unstructured":"Rose AJ, Vegiopoulos A, Herzig S . Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations. J Steroid Biochem Mol Biol 2010; 122: 10\u201320.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFhr201577_CR8","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1210\/endo.142.4.8114","volume":"142","author":"JR Seckl","year":"2001","unstructured":"Seckl JR, Walker BR . Minireview: 11beta-hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001; 142: 1371\u20131376.","journal-title":"Endocrinology"},{"key":"BFhr201577_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1210\/er.2003-0031","volume":"25","author":"JW Tomlinson","year":"2004","unstructured":"Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM . 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 2004; 25: 831\u2013866.","journal-title":"Endocr Rev"},{"key":"BFhr201577_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jsbmb.2009.12.013","volume":"119","author":"CA Staab","year":"2010","unstructured":"Staab CA, Maser E . 11beta-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. J Steroid Biochem Mol Biol 2010; 119: 56\u201372.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFhr201577_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.3283939","volume":"240","author":"RM Evans","year":"1988","unstructured":"Evans RM . The steroid and thyroid hormone receptor superfamily. Science 1988; 240: 889\u2013895.","journal-title":"Science"},{"key":"BFhr201577_CR12","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/0006-291X(87)90276-2","volume":"142","author":"SM Czerwinski-Helms","year":"1987","unstructured":"Czerwinski-Helms SM, Hickson RC . Specificity of activated glucocorticoid receptor expression in heart and skeletal muscle types. Biochem Biophys Res Commun 1987; 142: 322\u2013328.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFhr201577_CR13","first-page":"2519","volume":"85","author":"KM Kayes-Wandover","year":"2000","unstructured":"Kayes-Wandover KM, White PC . Steroidogenic enzyme gene expression in the human heart. J Clin Endocrinol Metab 2000; 85: 2519\u20132525.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFhr201577_CR14","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1681\/ASN.2004121110","volume":"16","author":"HP Gaeggeler","year":"2005","unstructured":"Gaeggeler HP, Gonzalez-Rodriguez E, Jaeger NF, Loffing-Cueni D, Norregaard R, Loffing J, Horisberger JD, Rossier BC . Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line. J Am Soc Nephrol 2005; 16: 878\u2013891.","journal-title":"J Am Soc Nephrol"},{"key":"BFhr201577_CR15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/HYPERTENSIONAHA.108.119966","volume":"53","author":"JW Funder","year":"2009","unstructured":"Funder JW . Reconsidering the roles of the mineralocorticoid receptor. Hypertension 2009; 53: 286\u2013290.","journal-title":"Hypertension"},{"key":"BFhr201577_CR16","first-page":"59","volume":"76","author":"M Ohtake","year":"2014","unstructured":"Ohtake M, Hattori T, Murase T, Takahashi K, Takatsu M, Ohtake M, Miyachi M, Watanabe S, Cheng XW, Murohara T, Nagata K . Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats. Nagoya J Med Sci 2014; 76: 59\u201372.","journal-title":"Nagoya J Med Sci"},{"key":"BFhr201577_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/nutd.2010.1","volume":"1","author":"T Hattori","year":"2011","unstructured":"Hattori T, Murase T, Ohtake M, Inoue T, Tsukamoto H, Takatsu M, Kato Y, Hashimoto K, Murohara T, Nagata K . Characterization of a new animal model of metabolic syndrome: the DahlS.Z-Leprfa\/Leprfa rat. Nutr Diabetes 2011; 1: e1.","journal-title":"Nutr Diabetes"},{"key":"BFhr201577_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/hr.2011.157","volume":"35","author":"T Murase","year":"2012","unstructured":"Murase T, Hattori T, Ohtake M, Abe M, Amakusa Y, Takatsu M, Murohara T, Nagata K . Cardiac remodeling and diastolic dysfunction in DahlS.Z-Leprfa\/Leprfa rats: a new animal model of metabolic syndrome. Hypertens Res 2012; 35: 186\u2013193.","journal-title":"Hypertens Res"},{"key":"BFhr201577_CR19","first-page":"275","volume":"77","author":"K Takahashi","year":"2015","unstructured":"Takahashi K, Takatsu M, Matsuura N, Nagasawa K, Hattori T, Watanabe S, Murohara T, Nagata K . Roles of oxidative stress and the mineralocorticoid receptor in cardiac pathology in a rat model of metabolic syndrome. Nagoya J Med Sci 2015; 77: 275\u2013289.","journal-title":"Nagoya J Med Sci"},{"key":"BFhr201577_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/01.HYP.0000026668.50222.1E","volume":"40","author":"K Nagata","year":"2002","unstructured":"Nagata K, Somura F, Obata K, Odashima M, Izawa H, Ichihara S, Nagasaka T, Iwase M, Yamada Y, Nakashima N, Yokota M . AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats. Hypertension 2002; 40: 168\u2013174.","journal-title":"Hypertension"},{"key":"BFhr201577_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/hr.2010.9","volume":"33","author":"V Kotsis","year":"2010","unstructured":"Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G . Mechanisms of obesity-induced hypertension. Hypertens Res 2010; 33: 386\u2013393.","journal-title":"Hypertens Res"},{"key":"BFhr201577_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/hr.2014.53","volume":"37","author":"H Nakagami","year":"2014","unstructured":"Nakagami H, Pang Z, Shimosato T, Moritani T, Kurinami H, Koriyama H, Tenma A, Shimamura M, Morishita R . The dipeptidyl peptidase-4 inhibitor teneligliptin improved endothelial dysfunction and insulin resistance in the SHR\/NDmcr-cp rat model of metabolic syndrome. Hypertens Res 2014; 37: 629\u2013635.","journal-title":"Hypertens Res"},{"key":"BFhr201577_CR23","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1161\/01.HYP.36.5.912","volume":"36","author":"JA Whitworth","year":"2000","unstructured":"Whitworth JA, Mangos GJ, Kelly JJ . Cushing, cortisol, and cardiovascular disease. Hypertension 2000; 36: 912\u2013916.","journal-title":"Hypertension"},{"key":"BFhr201577_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00004872-199917030-00016","volume":"17","author":"M Li","year":"1999","unstructured":"Li M, Wen C, Fraser T, Whitworth JA . Adrenocorticotrophin-induced hypertension: effects of mineralocorticoid and glucocorticoid receptor antagonism. J Hypertens 1999; 17: 419\u2013426.","journal-title":"J Hypertens"},{"key":"BFhr201577_CR25","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1210\/en.2006-0658","volume":"147","author":"AJ Rickard","year":"2006","unstructured":"Rickard AJ, Funder JW, Fuller PJ, Young MJ . The role of the glucocorticoid receptor in mineralocorticoid\/salt-mediated cardiac fibrosis. Endocrinology 2006; 147: 5901\u20135906.","journal-title":"Endocrinology"},{"key":"BFhr201577_CR26","first-page":"R539","volume":"259","author":"SC Langley","year":"1990","unstructured":"Langley SC, York DA . Effects of antiglucocorticoid RU486 on development of obesity in obese fa\/fa Zucker rats. Am J Physiol 1990; 259: R539\u2013R544.","journal-title":"Am J Physiol"},{"key":"BFhr201577_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cardiores.2006.02.010","volume":"70","author":"K Lister","year":"2006","unstructured":"Lister K, Autelitano DJ, Jenkins A, Hannan RD, Sheppard KE . Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1. Cardiovasc Res 2006; 70: 555\u2013565.","journal-title":"Cardiovasc Res"},{"key":"BFhr201577_CR28","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1096\/fj.07-8357com","volume":"21","author":"Y Sainte-Marie","year":"2007","unstructured":"Sainte-Marie Y, Nguyen Dinh Cat A, Perrier R, Mangin L, Soukaseum C, Peuchmaur M, Tronche F, Farman N, Escoubet B, Benitah JP, Jaisser F . Conditional glucocorticoid receptor expression in the heart induces atrio-ventricular block. FASEB J 2007; 21: 3133\u20133141.","journal-title":"FASEB J"},{"key":"BFhr201577_CR29","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","volume":"47","author":"K Nagata","year":"2006","unstructured":"Nagata K, Obata K, Xu J, Ichihara S, Noda A, Kimata H, Kato T, Izawa H, Murohara T, Yokota M . Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats. Hypertension 2006; 47: 656\u2013664.","journal-title":"Hypertension"},{"key":"BFhr201577_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1210\/endo.143.1.8583","volume":"143","author":"KE Sheppard","year":"2002","unstructured":"Sheppard KE, Autelitano DJ . 11 Beta-hydroxysteroid dehydrogenase 1 transforms 11-dehydrocorticosterone into transcriptionally active glucocorticoid in neonatal rat heart. Endocrinology 2002; 143: 198\u2013204.","journal-title":"Endocrinology"},{"key":"BFhr201577_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejphar.2009.05.028","volume":"615","author":"T Yamada","year":"2009","unstructured":"Yamada T, Nagata K, Cheng XW, Obata K, Saka M, Miyachi M, Naruse K, Nishizawa T, Noda A, Izawa H, Kuzuya M, Okumura K, Murohara T, Yokota M . Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats. Eur J Pharmacol 2009; 615: 163\u2013170.","journal-title":"Eur J Pharmacol"},{"key":"BFhr201577_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0960-0760(94)90190-2","volume":"48","author":"DP McDonnell","year":"1994","unstructured":"McDonnell DP, Shahbaz MM, Vegeto E, Goldman ME . The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol 1994; 48: 425\u2013432.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFhr201577_CR33","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM . Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409\u20132415.","journal-title":"J Clin Invest"},{"key":"BFhr201577_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/01.HYP.0000118584.33350.7d","volume":"43","author":"F Kuwahara","year":"2004","unstructured":"Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T . Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 2004; 43: 739\u2013745.","journal-title":"Hypertension"},{"key":"BFhr201577_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/hr.2012.137","volume":"36","author":"F Paneni","year":"2013","unstructured":"Paneni F, Gregori M, Tocci G, Palano F, Ciavarella GM, Pignatelli G, Marra A, Sciarretta S, Ferrucci A, Volpe M . Do diabetes, metabolic syndrome or their association equally affect biventricular function? A tissue Doppler study. Hypertens Res 2013; 36: 36\u201342.","journal-title":"Hypertens Res"},{"key":"BFhr201577_CR36","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1530\/EJE-07-0455","volume":"157","author":"BR Walker","year":"2007","unstructured":"Walker BR . Glucocorticoids and cardiovascular disease. Eur J Endocrinol 2007; 157: 545\u2013559.","journal-title":"Eur J Endocrinol"},{"key":"BFhr201577_CR37","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I . Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752\u20131761.","journal-title":"J Clin Invest"},{"key":"BFhr201577_CR38","doi-asserted-by":"publisher","first-page":"R943","DOI":"10.1152\/ajpregu.00265.2004","volume":"287","author":"CM Boustany","year":"2004","unstructured":"Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA . Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 2004; 287: R943\u2013R949.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFhr201577_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/HYPERTENSIONAHA.108.111815","volume":"52","author":"H Matsui","year":"2008","unstructured":"Matsui H, Ando K, Kawarazaki H, Nagae A, Fujita M, Shimosawa T, Nagase M, Fujita T . Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder. Hypertension 2008; 52: 287\u2013294.","journal-title":"Hypertension"},{"key":"BFhr201577_CR40","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0022-3565(24)36928-9","volume":"282","author":"JC Clapham","year":"1997","unstructured":"Clapham JC, Turner NC . Effects of the glucocorticoid II receptor antagonist mifepristone on hypertension in the obese Zucker rat. J Pharmacol Exp Ther 1997; 282: 1503\u20131508.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFhr201577_CR41","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/0026-0495(92)90171-6","volume":"41","author":"P Marin","year":"1992","unstructured":"Marin P, Darin N, Amemiya T, Andersson B, Jern S, Bjorntorp P . Cortisol secretion in relation to body fat distribution in obese premenopausal women. Metabolism 1992; 41: 882\u2013886.","journal-title":"Metabolism"},{"key":"BFhr201577_CR42","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1172\/JCI114345","volume":"84","author":"H Hauner","year":"1989","unstructured":"Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R, Pfeiffer EF . Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 1989; 84: 1663\u20131670.","journal-title":"J Clin Invest"},{"key":"BFhr201577_CR43","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1126\/science.1066285","volume":"294","author":"H Masuzaki","year":"2001","unstructured":"Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS . A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166\u20132170.","journal-title":"Science"},{"key":"BFhr201577_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1172\/JCI17845","volume":"112","author":"H Masuzaki","year":"2003","unstructured":"Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS . Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003; 112: 83\u201390.","journal-title":"J Clin Invest"},{"key":"BFhr201577_CR45","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2337\/diabetes.49.6.883","volume":"49","author":"CT Montague","year":"2000","unstructured":"Montague CT, O'Rahilly S . The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000; 49: 883\u2013888.","journal-title":"Diabetes"},{"key":"BFhr201577_CR46","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","volume":"75","author":"R Kuhn","year":"1993","unstructured":"Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W . Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263\u2013274.","journal-title":"Cell"},{"key":"BFhr201577_CR47","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S0167-5699(97)01111-0","volume":"18","author":"T Wilckens","year":"1997","unstructured":"Wilckens T, De Rijk R . Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol Today 1997; 18: 418\u2013424.","journal-title":"Immunol Today"},{"key":"BFhr201577_CR48","first-page":"321","volume":"20","author":"NJ McKenna","year":"1999","unstructured":"McKenna NJ, Lanz RB, O'Malley BW . Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 1999; 20: 321\u2013344.","journal-title":"Endocr Rev"},{"key":"BFhr201577_CR49","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1210\/en.2012-2045","volume":"154","author":"S Vandevyver","year":"2013","unstructured":"Vandevyver S, Dejager L, Tuckermann J, Libert C . New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Endocrinology 2013; 154: 993\u20131007.","journal-title":"Endocrinology"},{"key":"BFhr201577_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","volume":"10","author":"JW Funder","year":"2005","unstructured":"Funder JW . Mineralocorticoid receptors: distribution and activation. Heart Fail Rev 2005; 10: 15\u201322.","journal-title":"Heart Fail Rev"},{"key":"BFhr201577_CR51","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1096\/fj.06-7970com","volume":"21","author":"M Caprio","year":"2007","unstructured":"Caprio M, Feve B, Claes A, Viengchareun S, Lombes M, Zennaro MC . Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 2007; 21: 2185\u20132194.","journal-title":"FASEB J"},{"key":"BFhr201577_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1677\/JOE-09-0292","volume":"204","author":"J Hoppmann","year":"2010","unstructured":"Hoppmann J, Perwitz N, Meier B, Fasshauer M, Hadaschik D, Lehnert H, Klein J . The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses. J Endocrinol 2010; 204: 153\u2013164.","journal-title":"J Endocrinol"},{"key":"BFhr201577_CR53","first-page":"R1106","volume":"262","author":"S Okada","year":"1992","unstructured":"Okada S, York DA, Bray GA . Mifepristone (RU486), a blocker of type II glucocorticoid and progestin receptors, reverses a dietary form of obesity. Am J Physiol 1992; 262: R1106\u2013R1110.","journal-title":"Am J Physiol"},{"key":"BFhr201577_CR54","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/oby.21033","volume":"23","author":"G Navarro","year":"2015","unstructured":"Navarro G, Allard C, Xu W, Mauvais-Jarvis F . The role of androgens in metabolism, obesity, and diabetes in males and females. Obesity (Silver Spring) 2015; 23: 713\u2013719.","journal-title":"Obesity (Silver Spring)"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201577","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T03:07:42Z","timestamp":1748488062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,9]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFhr201577"],"URL":"https:\/\/doi.org\/10.1038\/hr.2015.77","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,9]]},"assertion":[{"value":"3 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}